Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

The maximum human lifespan hasn't moved past 115 years. But is that about to change?

A landmark study due to start in the coming months aims to test a method for rejuvenating our immune system in older age. The ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...

In oncology, the manipulation of metabolic processes within tumors has surfaced as a pivotal strategy for influencing cancer progression and therapy resistance. Tumor cells often undergo metabolic ...

Andy Lupini, distinguished R&D staff member of ORNL’s Electron Microscopy and Microanalysis Group, and Kevin Roccapriore — on entrepreneurial leave from ORNL’s Data NanoAnalytics Group to launch the ...

Abstract: Accurate and timely air quality prediction is crucial for cities and individuals to effectively take necessary precautions against potential air pollution. Existing studies typically rely on ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Plus: SpaceX has officially delivered the largest IPO in history. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.